Sleep Pharmaceuticals Eisai to Present New Data On Lemborexant at SLEEP 2022 June 3, 2022 RTSleepWorld Read Article
Pharmaceuticals FDA Approves DAYVIGO for Treatment of Insomnia in Adults December 27, 2019 RTSleepWorld Read Article
Pharmaceuticals On-Road Driving Safety Study of Investigational Lemborexant Published in SLEEP® January 25, 2019 RTSleepWorld Read Article
Research Eisai and Purdue Pharma Announce Key Phase 1 Clinical Studies of Lemborexant to be Presented at SLEEP 2018 May 24, 2018 RTSleepWorld Read Article